These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3877565)

  • 41. Identification of T-cell antigens expressed by metastatic T-cell hybridomas and lymphomas.
    Van Hecke D; Verschueren H; De Baetselier P
    Int J Cancer; 1990 Apr; 45(4):773-82. PubMed ID: 2323852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated T hybridomas induce upregulation of B7-1 on bystander B lymphoma cells by a contact-dependent interaction utilizing CD40 ligand.
    Jones KW; Hackett CJ
    Cell Immunol; 1996 Nov; 174(1):42-53. PubMed ID: 8929453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
    Lu PH; Negrin RS
    J Immunol; 1994 Aug; 153(4):1687-96. PubMed ID: 7519209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation.
    Cui H; el-Khatib M; Sherr DH; Ettinger R; Sy MS; Marshak-Rothstein A; Ju ST
    Cell Immunol; 1996 Feb; 167(2):302-12. PubMed ID: 8603440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential generation of human T cell hybrids with a tetraploid fusion partner.
    Berger AE; Kuentzel SL; Davidson SO
    J Immunol; 1985 Sep; 135(3):1792-9. PubMed ID: 3874906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Difference in motile behavior between lymphoma variants with different invasive and metastatic capabilities.
    Verschueren H; Dekegel D; De Baetselier P
    Invasion Metastasis; 1988; 8(1):31-44. PubMed ID: 3343091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic morphology of metastatic mouse T-lymphoma cells invading through monolayers of 10T1/2 cells.
    Verschueren H; De Baetselier P; Bereiter-Hahn J
    Cell Motil Cytoskeleton; 1991; 20(3):203-14. PubMed ID: 1773448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced immunosuppressive activity associated with metastatic lymphoma cells.
    Hao W; McDonald TL; Brunson KW; Joshi SS
    Cancer Res; 1993 Apr; 53(8):1921-8. PubMed ID: 8385575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation.
    Sakano T; Wilbur SM; Bonavida B
    Cancer Res; 1985 Apr; 45(4):1573-8. PubMed ID: 3884142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Putative invasion-specific proteins in mouse T-cell hybridomas that differ in invasive and metastatic potential.
    La Rivière G; Schipper CA; Gebbinck JW; Koch G; Kuhn L; Lefkovits I; Roos E
    Int J Cancer; 1992 Jul; 51(5):745-53. PubMed ID: 1612783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further evidence for the existence of 'homing' receptors on murine leukemia cells which mediate adherence to normal bone marrow stromal cells.
    Kamenov B; Longenecker BM
    Leuk Res; 1985; 9(12):1529-37. PubMed ID: 3001437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.
    Larizza L; Schirrmacher V; Pflüger E
    J Exp Med; 1984 Nov; 160(5):1579-84. PubMed ID: 6491605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine.
    Habets GG; van der Kammen RA; Scholtes EH; Collard JG
    Clin Exp Metastasis; 1990; 8(6):567-77. PubMed ID: 1699692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The presence of retroviral particles in hybridoma cell lines.
    Machala O; Mach O; Bubeník J; Hasek M
    Folia Biol (Praha); 1986; 32(3):178-82. PubMed ID: 3017774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syngeneic in vivo passage of the murine BW 5147 lymphoma results in the expression of a stable metastatic phenotype.
    De Baetselier P; Roos E; van Hecke D; Verschaeve L; Brys L; Verschueren H
    Int J Cancer; 1988 May; 41(5):720-6. PubMed ID: 3259210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastatic competence of BW5147 T-lymphoma cell lines is correlated with in vitro invasiveness, motility and F-actin content.
    Verschueren H; Van der Taelen I; Dewit J; De Braekeleer J; De Baetselier P
    J Leukoc Biol; 1994 Apr; 55(4):552-6. PubMed ID: 8145027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the spleen in the organ-specific metastasis of murine BW 5147 T lymphomas.
    Schmidt C; Verschueren H; Toussaint-Demylle D; van den Berg T; Kraal G; De Baetselier P
    Clin Exp Metastasis; 1994 Mar; 12(2):164-74. PubMed ID: 8306530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.